MACCHIA, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 259
NA - Nord America 139
AS - Asia 65
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 466
Nazione #
US - Stati Uniti d'America 139
IE - Irlanda 100
IT - Italia 55
SG - Singapore 42
CZ - Repubblica Ceca 34
DE - Germania 19
CN - Cina 16
SE - Svezia 16
UA - Ucraina 8
FI - Finlandia 5
GB - Regno Unito 4
RS - Serbia 4
BE - Belgio 3
FR - Francia 3
GR - Grecia 3
IR - Iran 3
AT - Austria 2
IN - India 2
AU - Australia 1
EU - Europa 1
NL - Olanda 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 466
Città #
Dublin 100
Singapore 33
New York 28
Chandler 25
Brno 17
Olomouc 17
Munich 16
Bari 14
Boardman 13
Nyköping 12
Ashburn 7
Ann Arbor 5
Helsinki 5
Jacksonville 5
Bologna 4
Brussels 3
Dearborn 3
Kozani 3
London 3
Los Angeles 3
Manfredonia 3
Princeton 3
Seattle 3
Belgrade 2
Campobasso 2
Kashan 2
Mesagne 2
Milan 2
Monmouth Junction 2
Pune 2
Redwood City 2
Reggio Emilia 2
Almenno San Salvatore 1
Andover 1
Beijing 1
Boise 1
Buffalo 1
Chicago 1
Dammam 1
Foggia 1
Fulham 1
Genova 1
Guangzhou 1
Hefei 1
Jiaxing 1
Kish 1
Kragujevac 1
Laurel 1
Leves 1
North Babylon 1
Perugia 1
Provo 1
Rome 1
Ruski Krstur 1
Ruvo Di Puglia 1
San Jose 1
Santa Clara 1
Taipei 1
Thiene 1
Wilmington 1
Wuhan 1
Xuzhou 1
Yiwu 1
Totale 374
Nome #
FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY (FT-ICR-MS) FOR HIGH-RESOLUTION ANALYSIS OF FENNEL PROTEINS 87
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 69
Adult Renal Stem/Progenitor Cells Can Modulate T Regulatory Cells and Double Negative T Cells 61
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 51
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 34
Dermanyssosis in the Urban Context: When the One Health Paradigm Is Put into Practice 33
La disfunzione psicosomatica delle corde vocali 25
Wasp immunotherapy induced long-term and IgG4-independent protection 24
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità 21
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 20
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione 19
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 13
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 11
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 10
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis 10
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 9
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 8
Desensitization in Iron Product Allergy 8
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 7
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 5
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 5
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 5
Totale 535
Categoria #
all - tutte 4.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 8 3 3 0 2 1 3 0
2020/202119 1 0 1 1 1 0 1 2 7 2 1 2
2021/202230 1 1 3 1 0 2 0 0 9 6 0 7
2022/2023162 10 9 5 5 12 18 4 14 64 4 9 8
2023/2024230 11 0 43 1 10 87 4 7 3 0 0 64
2024/202573 21 4 18 10 20 0 0 0 0 0 0 0
Totale 535